Companion Society Meetings

North American Society of Head and Neck Pathology

A Modernized Approach to Neuroendocrine Tumors of the Head and Neck

Sunday, March 18, 2018, 1:30 - 5:00 PM

Session Credits:

3 CME and 3 SAMs

Moderator:

Michelle D. Williams, M.D., MD Anderson Cancer Center, Houston, TX

Course Description:

There is significant diversity of neuroendocrine tumors arising in the head and neck region, especially regarding their clinical behavior. Each presenter brings insight into the specific pathologic challenges in diagnosis and importantly the differential diagnosis and pathology factors important for patient care in each entity and anatomic area covered. Additionally, advances that have occurred in each area will be presented.

Learning Objectives:

Upon completion of this educational activity, the learner will be able to:

  • Define the spectrum of neuroendocrine entities that develop in the various subsites within the head and neck
  • Consider neuroendocrine tumors in the differential diagnosis based on subsites within head and neck and apply immunohistochemical tools for their diagnosis
  • Recognize evolving molecular and pathogenic factors that may contribute to neuroendocrine neoplasm in the head and neck

 

1:30 PM Introduction
Michelle D. Williams, M.D., MD Anderson Cancer Center, Houston, TX
1:35 PM Neuroendocrine carcinomas of the larynx and head and neck. Challenges in classification and grading
Bayardo Perez-Ordonez, MD, University of Toronto, Toronto, ON, Canada
2:00 PM Human Papillomavirus-Related Neuroendocrine Carcinomas of the Head and Neck
William H. Westra, MD, Icahn School of Medicine at Mount Sinai, New York, NY
2:25 PM Salivary Neuroendocrine Carcinomas - An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin
Rebecca D. Chernock, MD, Washington University, St. Louis, MO
2:50 PM Middle Ear Adenoma
Lester Thompson, MD, Woodland Hills Medical Center, Woodland Hills, CA
3:10 PM Break
3:30 PM Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma
Diana Bell, MD, MD Anderson Cancer Center, Houston, TX
4:00 PM Update on Merkel Cell Carcinoma
Michael T. Tetzlaff, MD, PhD, MD Anderson Cancer Center, Houston, TX

 

Continuing Medical Education and Maintenance of Certification

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and North American Society of Head and Neck Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

 

Return to 2018 Annual Meeting Companion Society Meetings Page

Meetings

view more